Important Zoonotic Disease with One Health implications...   U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report (MMWR) - March 29, 2013 / 62(RR03);1-23   Diagnosis and Management of Q Fever — United States, 2013: Recommendations from CDC and the Q Fever Working Group   The material in this report originated in the National Center for Emerging and Zoonotic Infectious Diseases, Beth P. Bell, MD, Director; and the Division of Vector-Borne Diseases, Lyle R. Petersen, MD, Director. Corresponding preparer: Alicia Anderson, DVM, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC, 1600 Clifton Road, MS A-30, Atlanta, GA 30333. Telephone: 404-639-4499; Fax: 404-639-2778; E-mail:   Summary Q fever, a zoonotic disease caused by the bacterium Coxiella burnetii, can cause acute or chronic illness in humans. Transmission occurs primarily through inhalation of aerosols from contaminated soil or animal waste. No licensed vaccine is available in the United States. Because many human infections result in nonspecific or benign constitutional symptoms, establishing a diagnosis of Q fever often is challenging for clinicians. This report provides the first national recommendations issued by CDC for Q fever recognition, clinical and laboratory diagnosis, treatment, management, and reporting for health-care personnel and public health professionals. The guidelines address treatment of acute and chronic phases of Q fever illness in children, adults, and pregnant women, as well as management of occupational exposures. These recommendations will be reviewed approximately every 5 years and updated to include new published evidence.